Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Avvinity Therapeutics

Avvinity Therapeutics
2016 FOUNDED
PRIVATE STATUS
Joint Venture LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of immuno-oncology therapeutics. The company specializes in drug discovery, immunology, gene editing and oncology for the treatment of both solid tumours and leukemia.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery

Avvinity Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Avvinity Therapeutics‘s full profile, request access.

Request full access to PitchBook

Avvinity Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Avvinity Therapeutics‘s full profile, request access.

Request full access to PitchBook

Avvinity Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Darrin Disley Ph.D Director & Co-Founder